Track topics on Twitter Track topics that are important to you
Edison Investment Research - Pharmaceutical & Healthcare - Photocure: Photocure announced the second quarter of record sales, NOK33.5m or 18% growth year-on-year and 26% growth in Hexvix/Cysview sales. The growth was on the back of an increase of 20% in unit sales and 23% in revenue from the Nordic region, which marks a return to growth in the region following a slow (5% unit loss) Q415. Sales wer...
A new study of when soldiers try to kill themselves “helps identify vulnerable transitions for men and women serving in the military.”
Coral reefs - stunning, critical habitats for an enormous array of prized fish and other species - have survived five major extinction events over the last 250 million years.Read more about Scientists Create World's Largest Coral Gene Database
Sanofi has filed documents seeking to remove the current Medivation board of directors and replace it with eight individuals that are willing to “fairly evaluate” Sanofi’s acquisition offer
Read more about Methane-producing Microbes Discovered in California Rocks
Nano Dimension and Accelta have successfully lab-tested a proof of concept 3D bioprinter.
Here’s a meta-question for you: to what extent can we scientists explain what we do, and to what extent does that change anyone’s mind? That sounds like a cry of despair, but it’s not. As someone who writes about science for a mixed audience, though, it does cross my mind. A few recent examples: here’s an
A selection of opinions on health care from around the country.
Editorial and opinion writers offer their take on drug-cost issues.
News outlets report on the pharmaceutical drug industry.
Concordia Healthcare bought a drug to treat irritable bowel syndrome when a prescription for the medication cost about $87. Now it sells at $782.
Outlets report on health news from Vermont, California, North Carolina, New Hampshire, Florida, Detroit, Wisconsin, Delaware, Iowa, Pennsylvania and Ohio.
The plastic mesh is used to treat pelvic organ prolapse. In response to thousands of injuries from the mesh, the Food and Drug Administration early this year re-labeled the products high risk instead of moderate and announced new federal scrutiny for them.
A proposal by state officials to let the private insurance companies that manage the Medicaid program designate preferred providers and pay them more was questioned by consumers and providers at a public hearing. Also, the recent decision on Medicaid services by Arizona's high court did not resolve a key issue.
In other news, Vice President Joe Biden will host a national cancer research summit in June.
Scientist Ira Pastor believes brain death is a potentially curable condition, given the right combination of stem cells, drugs, electrical currents, magnetic fields or other stimuli. But his quest to explore the idea is being greeted with skepticism, confusion and worries of a zombie apocalypse.
Studies have long shown that most obese diabetics who undergo bariatric surgery see their blood sugar control dramatically improve.
Will collaborate with TriNetX, using its electronic medical records network
Theranos, the $9-billion company built around the concept of a fingerprick blood draw for dozens of tests, has voided two years’ worth of diagnostics done with its marquee technology.Read more about Theranos Voids Two Years of Tests Amid Building PressureComments
New recommendations call for the elimination of routine wellness visits in adults, but the suggestions may have been based on questionable evidence.
Sanofi is moving to replace each member of the Medivation board with eight independent candidates.
Allergan announced that the New Drug Application (NDA) filing for oxymetazoline HCl cream 1.0 percent, an investigational topical prescription product for the treatment of persistent facial erythema (redness) associated with rosacea in adults, has been accepted by the U.S. Food and Drug Administration (FDA) for standard review. Allergan expects the Prescription Drug User Fee Act (PDUFA) date to...
Edison Investment Research - Pharmaceutical & Healthcare - Tonix Pharmaceuticals: Tonix reported positive Phase II results for TNX-102 SL (sublingual formulation of cyclobenzaprine) marking the first-ever large multicenter trial for military-related PTSD. The 237-person study compared two dosage levels (2.8mg and 5.6mg) against placebo and found a significant improvement for the 5.6mg dose (p=0.03...
Viruses attack cells and commandeer their machinery in a complex and carefully orchestrated invasion. Scientists have long probed this process for insights into biology and disease, but essential details still remain out of reach.Read more about Scienti
Colorcon and BASF advance co-operation to strengthen their pharmaceutical film coating operations